BioCentury
ARTICLE | Clinical News

Solulin: Phase Ib started

September 5, 2011 7:00 AM UTC

Paion began an open-label, international Phase Ib trial to evaluate single doses of IV Solulin in patients with severe hemophilia A receiving chronic therapy with coagulation Factor VIII. ...